<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brooks Laboratories has filed a compliance disclosure confirming that it does not qualify as a 'Large Corporate' under SEBI's framework for mandatory debt securities fund raising for the financial year ended 31st March 2025. As per the disclosure, the company's outstanding borrowing as on 31st March 2025 stands at just Rs. 0.13 crore, which is well below the threshold that triggers Large Corporate classification. The company's credit rating from Care Ratings is BB-, a non-investment grade rating. Since the company is not classified as a Large Corporate, it has no mandatory obligation to raise a minimum portion of its borrowings through debt markets, and consequently no fine liability applies.
This is a routine annual compliance filing with no material impact on shareholders or stock price. It simply confirms that Brooks Laboratories is a small borrower and does not face SEBI's mandatory debt market borrowing requirements.